跳至主要内容
临床试验/NCT07449260
NCT07449260已完成不适用

Is TSH Level in Serum Affect ICSI Outcome?

Cairo University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2019年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
1
主要终点
ICSI outcome and its relation with TSH level

研究概览

简要总结

TSH has been suggested to be involved in reproductive challenges such as ovulatory issues, infertility, miscarriage, and maternal complications for many years.

Multiple studies have associated thyroid function with ovarian function and reproductive physiology. The thyroid hormone can impact follicle development, as well as the metabolism of estrogen and androgen, the menstrual cycle, and the receptivity of the endometrium

详细描述

In a region with adequate iodine levels, a TSH threshold of 4.12 mIU/L should be regarded as the upper limit of normal. The Chinese Society for Reproductive Medicine suggests that infertile women and those trying to conceive should consider a TSH level between 4-4.5 mIU/L for subclinical hypothyroidism.

Hence, it is recommended that women aiming for in vitro fertilization (IVF) should have a TSH level of 4 mIU/L or lower. Studies have shown that infertile patients with untreated TSH levels >2.5 mIU/L before IVF/intracytoplasmic sperm injection (ICSI) had better pregnancy results when their TSH levels were <2.5 mIU/L compared to those with TSH >2.5 mIU/L.

In this study the aim was to Examine the clinical characteristics and results in infertile individuals with varying thyroid stimulating hormone (TSH) levels during ICSI, and determining which TSH levels cutoff impact the outcomes of ICSI or not.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Body mass index (BMI): women with BMI 18 : 30 kg/m
  • Favorable (average) responders to IVF stimulation: Anti-mullirian hormone (AMH) level >1.0 ng/mL but <3.5 ng/mL and antral follicular count (AFC) 5-
  • The embryos were transferred freshly or frozen .
  • Medically free

排除标准

  • Women with polycystic ovary syndrome (PCOS).
  • Poor ovarian response.
  • Severe teratoathenospermia.
  • women with chronic disease

研究组 & 干预措施

Group A

Patients with TSH<2.5 miu/L

干预措施: Basal TSH level (Other)

Group B

Patients with TSH 2.5-4 miu/L

干预措施: Basal TSH level (Other)

结局指标

主要结局

ICSI outcome and its relation with TSH level

时间窗: 4years

Number of oocyte retrieved , percentage of fertilization rate, cleavage rate, available embryo rate, pregnancy rate analyzed to explore whether serum TSH level in miu/L affect ourtcome or not .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaimaa Mostafa Mohammed Refaay El shemy

Assistant professor of Obstetrics and Gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验